FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

This adverse event was reported 24 times

These drugs are most commonly taken by patients reporting FIBRODYSPLASIA OSSIFICANS PROGRESSIVA:

# Drug Count
0 IMATINIB 15
1 IBUPFROFEN 14
2 IBUPROFEN 14
3 IBUPROFEN 200 MG 14
4 IBUPROFEN 200MG 14
5 IBUPROFEN CAPSULE 14
6 IBUPROFEN CAPSULES 200 MG 14
7 IBUPROFEN ORAL 14
8 IBUPROFEN TABLET, FILM COATED 14
9 IBUPROFEN TABLET, FILM-COATED 14
See all common drugs associated with FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

FIBRODYSPLASIA OSSIFICANS PROGRESSIVA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PALOVAROTENE 10 0.1408
1 CANAKINUMAB 1 0.0001
2 PREDNISOLONE ORAL SOLUTION 14 0.0001
3 IMATINIB MESYLATE 2 0.0001
4 IBUPFROFEN 14 0.0001
5 IBUPROFEN TABLETS USP, 200MG 14 0.0001
6 IBUPROFEN ORAL 14 0.0001
7 IBUPROFEN CAPSULES 200 MG 14 0.0001
8 MONTELUKAST SODIUM 8 0.0001
9 ANAKINRA 1 0.0001
See all drugs enriched for association with FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

FIBRODYSPLASIA OSSIFICANS PROGRESSIVA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Leukotriene Receptor Antagonist [EPC] 8 0.0003
1 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
2 Bile Acid [EPC] 1 0.0000
3 Retinoid [EPC] 10 0.0000
4 Alkylating Drug [EPC] 3 0.0000
5 Corticosteroid [EPC] 14 0.0000
6 Nonsteroidal Anti-inflammatory Drug [EPC] 14 0.0000
7 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
8 Insulin Analog [EPC] 4 0.0000
9 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
See all drug classes enriched for association with FIBRODYSPLASIA OSSIFICANS PROGRESSIVA